2022
DOI: 10.5603/cj.a2022.0007
|View full text |Cite
|
Sign up to set email alerts
|

A novel hybrid catheter-directed technique to treat intermediate-high risk pulmonary embolism

Abstract: This article has been peer reviewed and published immediately upon acceptance.It is an open access article, which means that it can be downloaded, printed, and distributed freely, provided the work is properly cited. Articles in "Cardiology Journal" are listed in PubMed.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…In some patients without absolute contraindications to thrombolysis, a combination (hybrid) pharmacomechanical treatment is possible, namely, thrombectomy supplemented with low-dose thrombolysis administered before, during, or after the catheter-directed procedure, especially if thrombectomy is not effective enough [40,41].…”
Section: Catheter-directed Mechanical Thrombectomymentioning
confidence: 99%
“…In some patients without absolute contraindications to thrombolysis, a combination (hybrid) pharmacomechanical treatment is possible, namely, thrombectomy supplemented with low-dose thrombolysis administered before, during, or after the catheter-directed procedure, especially if thrombectomy is not effective enough [40,41].…”
Section: Catheter-directed Mechanical Thrombectomymentioning
confidence: 99%
“…To circumvent these disadvantages, another system available on the market (Penumbra Indigo ® System, Penumbra, Alameda, CA, USA) implements automatic suction, ensuring consistent and labor-free suction through an 8F catheter [ 31 , 32 ]. This system also uses a retractable separator that moves back and forth, thus facilitating thrombus fragmentation [ 33 ]. The short-term (48 h) safety and efficacy of the Penumbra Indigo ® System was confirmed in the EXTRACT-PE study [ 31 ].…”
Section: Devices and Technical Details For Cdthmentioning
confidence: 99%
“…The recent development of advanced endovascular therapies aims to reduce PE-related morbidity and mortality [1,2]. CDMT involves devices for mechanical thrombus fragmentation and aspiration to quickly relieve the blockage and restore pulmonary blood flow with a subsequent improvement in the hemodynamic status in intermediate or high-risk PE [3,4]. The key innovations of the novel Lightning 12 system are the new CAT12 catheter, with a large 0.131'' lumen and angled tip for an additional circumferential sweep, and the lighting control unit with a pressure/flow sensor system and high-frequency valves.…”
mentioning
confidence: 99%